FROMILID

This brand name is authorized in Albania, Estonia, Croatia, Lithuania, Malta, Poland, Romania

Active ingredients

The drug FROMILID contains one active pharmaceutical ingredient (API):

1 Clarithromycin UNII H1250JIK0A - CLARITHROMYCIN

Clarithromycin is a semi-synthetic derivative of erythromycin A. It exerts its antibacterial action by selectively binding to the 50s ribosomal sub-unit of susceptible bacteria preventing translocation of activated amino acids. It inhibits the intracellular protein synthesis of susceptible bacteria. Read about Clarithromycin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01FA09	Clarithromycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FA Macrolides
Discover more medicines within J01FA09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AL	Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor	Identifier(s): 360/73, 361/73
Country: EE	Ravimiamet	Identifier(s): 1011687, 1028876, 1028887, 1141276, 1141287, 1141298, 1141300
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-148376472, HR-H-287481891, HR-H-431870434, HR-H-755419838
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1003029, 1003030, 1003031, 1004159, 1011841, 1011842, 1011843, 1021398, 1074831, 1089022, 1090722
Country: MT	Medicines Authority	Identifier(s): MA982/02501, MA982/02502, MA982/02801
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100081700, 100131443, 100140169, 100194060, 100248286, 100372483, 100379769, 100394585, 100410048
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W08490001, W08491001, W41838001, W41838002, W41838003